Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1969 1
1971 1
1974 1
1976 1
1978 1
1980 1
1981 1
1982 1
1983 1
1989 1
1990 1
1994 1
1996 2
1997 3
2001 1
2005 1
2006 5
2007 2
2008 3
2009 8
2010 10
2011 9
2012 15
2013 6
2014 6
2015 6
2016 10
2017 24
2018 23
2019 16
2020 13
2021 10
2023 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

151 results

Results by year

Filters applied: . Clear all
Page 1
SIMPLIFY-1: A Phase III Randomized Trial of Momelotinib Versus Ruxolitinib in Janus Kinase Inhibitor-Naïve Patients With Myelofibrosis.
Mesa RA, Kiladjian JJ, Catalano JV, Devos T, Egyed M, Hellmann A, McLornan D, Shimoda K, Winton EF, Deng W, Dubowy RL, Maltzman JD, Cervantes F, Gotlib J. Mesa RA, et al. J Clin Oncol. 2017 Dec 1;35(34):3844-3850. doi: 10.1200/JCO.2017.73.4418. Epub 2017 Sep 20. J Clin Oncol. 2017. PMID: 28930494 Free PMC article. Clinical Trial.
DIPSS plus: a refined Dynamic International Prognostic Scoring System for primary myelofibrosis that incorporates prognostic information from karyotype, platelet count, and transfusion status.
Gangat N, Caramazza D, Vaidya R, George G, Begna K, Schwager S, Van Dyke D, Hanson C, Wu W, Pardanani A, Cervantes F, Passamonti F, Tefferi A. Gangat N, et al. J Clin Oncol. 2011 Feb 1;29(4):392-7. doi: 10.1200/JCO.2010.32.2446. Epub 2010 Dec 13. J Clin Oncol. 2011. PMID: 21149668
Prognostication in primary myelofibrosis.
Cervantes F, Pereira A. Cervantes F, et al. Curr Hematol Malig Rep. 2012 Mar;7(1):43-9. doi: 10.1007/s11899-011-0102-1. Curr Hematol Malig Rep. 2012. PMID: 22072485
Management of Myelofibrosis-Related Cytopenias.
Bose P, Verstovsek S. Bose P, et al. Curr Hematol Malig Rep. 2018 Jun;13(3):164-172. doi: 10.1007/s11899-018-0447-9. Curr Hematol Malig Rep. 2018. PMID: 29796726 Review.
A clinical-molecular prognostic model to predict survival in patients with post polycythemia vera and post essential thrombocythemia myelofibrosis.
Passamonti F, Giorgino T, Mora B, Guglielmelli P, Rumi E, Maffioli M, Rambaldi A, Caramella M, Komrokji R, Gotlib J, Kiladjian JJ, Cervantes F, Devos T, Palandri F, De Stefano V, Ruggeri M, Silver RT, Benevolo G, Albano F, Caramazza D, Merli M, Pietra D, Casalone R, Rotunno G, Barbui T, Cazzola M, Vannucchi AM. Passamonti F, et al. Leukemia. 2017 Dec;31(12):2726-2731. doi: 10.1038/leu.2017.169. Epub 2017 May 31. Leukemia. 2017. PMID: 28561069
Survival analysis, more than meets the eye.
Lucijanic M, Skelin M, Lucijanic T. Lucijanic M, et al. Biochem Med (Zagreb). 2017 Feb 15;27(1):14-18. doi: 10.11613/BM.2017.002. Biochem Med (Zagreb). 2017. PMID: 28392721 Free PMC article. Review.
[Clinical aspects of primary myelofibrosis in Japan].
Shimoda K, Takenaka K, Kitanaka A, Akashi K. Shimoda K, et al. Rinsho Ketsueki. 2014 Mar;55(3):289-94. Rinsho Ketsueki. 2014. PMID: 24681931 Review. Japanese. No abstract available.
151 results